Cyclopharm is an established Australian radiopharmaceutical company servicing the global medical community since 1986.

Cyclopharm is a company in the diagnostic imaging field specialising in lung health. We achieve this positioning through our proprietary medical device and pharmaceutical products under the name of TECHNEGASTM.

TECHNEGASTM has become the industry gold-standard in diagnostic functional lung imaging technology.

We distribute our products in 57 countries throughout the world with over 1500 nuclear medicine departments utilising TECHNEGASTM.

To date, over 4.2 million patient procedures are recorded.

Latest Media Releases

Cyclopharm Results Summary

25/02/2021 12:29:00

Cyclopharm Limited (ASX: CYC) is pleased to provide the following update on its business and financial performance for FY2020, including progress towards gaining United States Food and Drug Administ…

Latest News